Pfizer Inc (PFE)
25.27
-1.00
(-3.81%)
USD |
NYSE |
Apr 25, 16:00
25.40
+0.13
(+0.51%)
After-Hours: 20:00
Pfizer Price: 25.27 for April 25, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 24, 2024 | 26.25 | 26.34 | 26.04 | 26.27 | 23.39M |
Apr 23, 2024 | 26.33 | 26.47 | 26.19 | 26.32 | 24.30M |
Apr 22, 2024 | 26.00 | 26.50 | 25.92 | 26.26 | 35.68M |
Apr 19, 2024 | 25.39 | 26.00 | 25.35 | 26.00 | 38.37M |
Apr 18, 2024 | 25.35 | 25.46 | 25.23 | 25.39 | 35.79M |
Apr 17, 2024 | 25.69 | 25.69 | 25.26 | 25.42 | 43.83M |
Apr 16, 2024 | 25.82 | 25.98 | 25.68 | 25.69 | 28.89M |
Apr 15, 2024 | 25.91 | 26.17 | 25.75 | 25.91 | 35.66M |
Apr 12, 2024 | 26.25 | 26.32 | 25.83 | 25.86 | 43.03M |
Apr 11, 2024 | 26.35 | 26.45 | 26.13 | 26.34 | 32.81M |
Apr 10, 2024 | 26.52 | 26.59 | 26.16 | 26.32 | 44.54M |
Apr 09, 2024 | 26.77 | 27.42 | 26.65 | 26.78 | 45.19M |
Apr 08, 2024 | 26.60 | 26.82 | 26.52 | 26.58 | 24.43M |
Apr 05, 2024 | 26.56 | 26.70 | 26.35 | 26.66 | 39.88M |
Apr 04, 2024 | 27.31 | 27.40 | 26.64 | 26.65 | 41.92M |
Apr 03, 2024 | 27.51 | 27.75 | 27.20 | 27.22 | 36.83M |
Apr 02, 2024 | 27.57 | 27.75 | 27.41 | 27.55 | 32.45M |
Apr 01, 2024 | 27.76 | 27.87 | 27.58 | 27.72 | 26.60M |
Mar 28, 2024 | 27.82 | 28.12 | 27.72 | 27.75 | 40.47M |
Mar 27, 2024 | 27.71 | 27.94 | 27.54 | 27.78 | 34.25M |
Mar 26, 2024 | 27.45 | 27.63 | 27.31 | 27.59 | 38.22M |
Mar 25, 2024 | 27.24 | 27.48 | 27.10 | 27.43 | 31.11M |
Mar 22, 2024 | 27.47 | 27.84 | 27.34 | 27.36 | 28.83M |
Mar 21, 2024 | 27.75 | 28.04 | 27.63 | 27.66 | 29.63M |
Mar 20, 2024 | 27.48 | 27.74 | 27.21 | 27.70 | 34.47M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
25.27
Minimum
Apr 25 2024
61.25
Maximum
Dec 16 2021
39.53
Average
37.72
Median
Jan 24 2020
Price Benchmarks
Amgen Inc | 269.58 |
Gilead Sciences Inc | 65.28 |
Johnson & Johnson | 146.84 |
Viking Therapeutics Inc | 68.90 |
Moderna Inc | 106.19 |
Price Related Metrics
PE Ratio | 70.19 |
PS Ratio | 2.455 |
Price to Book Value | 1.603 |
Price to Free Cash Flow | 29.96 |
Earnings Yield | 1.42% |
Market Cap | 142.69B |
Operating PE Ratio | 42.75 |
Normalized PE Ratio | 23.74 |